DOI: 10.36347/sjams.2021.v09i11.020

Pages: 1750-1753

Introduction: Blood transfusion therapy has a huge role in management of various hematological and other diseases. The prevention of transfusion-transmitted infections remains a key component of blood safety. The main objective of this study is to study the seroprevalence of viral markers on donated blood at the Blood Transfusion Center, Mohammed V Military Hospital in Rabat. Material and methods: This is a retrospective study conducted with military donors aged 19 to 50 at the Blood Transfusion Center (CTS) of the Mohammed V Military Hospital of Instruction (HMIMV), Rabat (Morocco), carried out over a period of four years from January 1, 2017 to December 31, 2020. Biological screening was carried out by a technique…. based on the principle of Results: Out of 49,703 samples tested, 48,175 were valid for transfusion and 1,528 were not valid for transfusion, among these invalid bags, 101 donations were confirmed positive for HBV (2 ‰), with an HCV seroprevalence of 1.2 ‰ (58 donations) and a seroprevalence of 0.5 ‰ (25 cases) of HIV 1 + 2 with a seroprevalence of 0.5 ‰ (25 cases). Discussion: The low rates of seroprevalence of viral markers in our study show improved preventive measures with regard to donor selection and screening tests. Conclusion: This perceived prevalence encourages the maintenance of the use of the combined reagent, which is the only alternative to molecular biology for developing countries.